Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supernus Pharmaceuticals Inc.

www.supernus.com

Latest From Supernus Pharmaceuticals Inc.

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Approvals Drug Review

Supernus’ ADHD Drug Hits Phase III Endpoint As Filing Beckons

The first of two Phase III trials of Supernus’ ADHD candidate has hit its endpoints in adolescents. The second is due to report in early 2019, setting the stage for regulatory filings.

Clinical Trials Research & Development

Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Start-Up Quarterly Statistics: Q3 Financings Slump Despite Large Gossamer Series B, Big Rubius IPO

Third quarter biopharma start-up financing activity decreased from the record-breaking Q2. A review of biopharma start-up dealmaking and financing activity from July through September 2018, based on data from Strategic Transactions.

Deals StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Pharmavene Inc.
  • Shire Laboratories Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Supernus Pharmaceuticals Inc.
  • Senior Management
  • Jack A Khattar, Pres. & CEO
    Gregory S Patrick, CFO
    Padmanabh P Bhatt, PhD, SVP, IP & CSO
    Victor Vaughn, SVP, Sales & Mktg.
    Stefan Schwabe, PhD, MD, CMO & EVP, R&D
    Tami T Martin, RN, SVP, Reg. Affairs
    Bryan A Rocklein, VP, Corp. Dev.
  • Contact Info
  • Supernus Pharmaceuticals Inc.
    Phone: (301) 838-2500
    1550 E. Gude Dr.
    Rockville, MD 20850
    USA
UsernamePublicRestriction

Register